tiprankstipranks
TipRanksTop Financial ExpertsInsidersAdam Koppel

Adam Koppel Insider Profile

11 Followers
Adam Koppel, Director, Ten Percent Owner at Kailera Therapeutics, Inc., holds 22.58M shares in Kailera Therapeutics, Inc. (Ticker: KLRA), holds 0.00 shares in Cerevel Therapeutics Holdings (Ticker: CERE), holds 4.03M shares in Solid Biosciences (Ticker: SLDB).
See the Hottest Stocks Based on Insider Trading >
tipranks
Adam Koppel

Adam Koppel
Kailera Therapeutics, Inc. (KLRA)
Director, Ten Percent Owner

Ranked #4,147 out of 108,921 Corporate Insiders

Profitable Transactions

67%
4 out of 6 Profitable Transactions

Average Return

+73.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$572M
64.83%
28.06%
7.00%
0.11%
0.00% Others
A breakdown of Adam Koppel's holdings
See the Top Stocks by Insiders

Insider Roles

Kailera Therapeutics, Inc.
(KLRA)
Director, Ten Percent Owner
PTC Therapeutics
(PTCT)
Director
Solid Biosciences
(SLDB)
Director, Ten Percent Owner
Biogen
(BIIB)
EVP, Strategy and Bus. Dev
+2 other positions
Roles that Adam Koppel holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Cerevel Therapeutics Holdings
(CERE)
Rating:Informative Buy
Date:Oct 29, 2020 - Oct 29, 2021
Return:+306.50%
The most profitable trade made by Adam Koppel
See the Latest Stocks Traded by Insiders

Adam Koppel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KLRA
Kailera Therapeutics, Inc.
Apr 20, 2026
Director, Ten Percent Owner
Uninformative Buy
―
$371.04M
BIIB
Biogen
Jun 07, 2016
EVP, Strategy and Bus. Dev
Uninformative Sell
160.95K
$628.36K
DRNA
Dicerna Pharma
Dec 06, 2019
―
Informative Sell
37.02M
$117.85M
SLDB
Solid Biosciences
Jan 12, 2024
Director, Ten Percent Owner
Uninformative Buy
5.00M
$40.06M
APTX
Aptinyx
Jan 16, 2020
―
Informative Buy
10.00M
$533.61K
BLSA
BCLS Acquisition
Oct 26, 2020
―
Uninformative Buy
4.88M
$4.89M
CERE
Cerevel Therapeutics Holdings
Aug 05, 2024
―
Uninformative Sell
―
$0.00
FHTX
Foghorn Therapeutics
―
Director
―
―
PTCT
PTC Therapeutics
Jun 27, 2013
Director
Uninformative Buy
―
$160.56M
TRVN
Trevena
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Adam Koppel's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Adam Koppel insider profile FAQ

What is the percentage of profitable transactions made by Adam Koppel?
The percentage of profitable transactions made by Adam Koppel is 67%.
    What is the average return per transaction made by Adam Koppel?
    The average return per transaction made by Adam Koppel is 73.70%.
      What stocks does Adam Koppel hold?
      Adam Koppel holds: KLRA, BIIB, DRNA, SLDB, APTX, BLSA, CERE, FHTX, PTCT, TRVN stocks.
        What was Adam Koppel’s latest transaction?
        Adam Koppel latest transaction was an Uninformative Buy of ―.
          What was Adam Koppel's most profitable transaction?
          Adam Koppel’s most profitable transaction was an Informative Buy of CERE stock on October 29, 2020. The return on the trade was 306.50%.
            What is Adam Koppel's role in Kailera Therapeutics, Inc.?
            Adam Koppel's role in Kailera Therapeutics, Inc. is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.